RR

Rupali Rahul Kondalkar

Active Director Director DIN 09456416
DIN 09456416 First appointment Jan 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value •••• Premium profile

About Rupali Rahul Kondalkar

Data last updated:

Rupali Rahul Kondalkar is a Director at Ricrisa Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals. Ricrisa Pharmaceuticals Private Limited reported revenue of ₹9.9 Lakh (FY 2025).

DIN 09456416
Primary Designation Director
Industry Chemicals
First Appointment 04 Jan 2022
Oldest Company Age 4 yrs
Largest company Ricrisa Pharmaceuticals Private Limited · ₹9.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Jan 20222022₹9.9 Lakh (FY 2025)Active

Board colleagues of Rupali Rahul Kondalkar

Directorship timeline

Open interactive timeline →
Ricrisa Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rupali Rahul Kondalkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rupali Rahul Kondalkar

Rupali Rahul Kondalkar currently holds 1 directorship: Ricrisa Pharmaceuticals Private Limited (Director, since 04 Jan 2022, revenue ₹9.9 Lakh (FY 2025)).

Rupali Rahul Kondalkar was first appointed on 04 Jan 2022 as Director at Ricrisa Pharmaceuticals Private Limited.

The current boards of Rupali Rahul Kondalkar's companies include Nitesh Madhukar Lad (Ricrisa Pharmaceuticals Private Limited), Sneha Shyamkant Suryawanshi (Ricrisa Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available